August 15, 2010

• Hansjörg Wyss to Receive 2011 Ellerin Award
• New Session: The Healthcare Market - Opportunities in Executive Management
• Deadline for Conference Roundtable Submissions Extended

• David Green Elected President of HBS Healthcare Alumni
• Mara Aspinall selected for The PharmaVOICE 100 list : Commanders and Chiefs
• Complete Genomics Files for IPO
• Engage with HBS MBA Students Interested in Healthcare
• New and Renewing HBS Health Members

Hansjörg Wyss to Receive 2011 Ellerin Award

Hansjörg Wyss, MBA '65 is this year's recipient of the Beatrice D. Ellerin Award for Alumni Achievement.

Mr. Wyss is the Chairman of Synthes, Inc. a global medical device company whose surgical instruments and implants have revolutionized the way surgeons treat the traumas that can afflict the human skeleton.

In 2008 he donated $125 million to Harvard University to create The Wyss Institute for Biologically Inspired Engineering. Investigators at the Wyss Institute strive to uncover the engineering principles that govern living things, and use this knowledge to develop technology solutions for the most pressing healthcare and environmental issues facing humanity. Wyss' gift is the largest individual gift in the University's history.

Mr. Wyss will accept his award on Friday evening, November 5th during the 11th Annual HBS Health Industry Alumni Conference.

New Session: The Healthcare Market - Opportunities in Executive Management

Looking for a job? Talk directly with the experts!

This year's conference will feature a panel of senior human resources executives who will discuss the current and prospective market for healthcare executives. The panelists will also network with conference participants during the coffee break and respond directly to personal inquiries.

Current participants include:

• Chuck Bolton - President, The Bolton Group (executive coach)
  
• Elizabeth Bolgiano - SVP of Human Resources, Thermo Fisher Scientific
  
• Russ Campanello - SVP of Human Resources, Phase Forward
  
• John Letcher - SVP of Human Resources, PerkinElmer

This session is meant to be interactive an actionable. Please look for more details in upcoming eblasts and newsletters.

Deadline for Conference Roundtable Submissions Extended

The deadline for roundtable submissions has been extended to September 15, 2010.

The goal of the Roundtable Discussions is to get executives to exchange valuable ideas and experiences on some of the most important issues facing the business of healthcare. The Roundtables are scheduled to take place over breakfast on Saturday November 6 from 8:30 am to 9:45 am. Topics are not tied to the overall theme of the conference, allowing for a wide range of healthcare discussions. Roundtable leaders receive a significant discount ($395 vs. $675 early bird rate) on the conference registration fee. This year we plan to have 12 roundtable positions and expect competition for the slots to be strong.

If you are interested in hosting a roundtable at this year’s conference please send a 1-sentence topic, 80-word-max description, and 30-word-max bio to both Steve Wardell at swardell@mba2000.hbs.edu and Justin Silver at jsilver@mba2008.hbs.edu. The roundtable chairs will review the entries and get back to the applicants in September. Roundtable leaders should prepare opening remarks, optional discussion materials and be prepared for a participatory roundtable discussion.

Roundtable topics at the 10th Annual HBS HIAC included:

• Leveraging Millions in Non-Dilutive Financing for Your Early Stage Healthcare Company

• Patient Centered Medical Home: An Expanding Vision for Health Reform
  
• The Increasing Importance of Emerging Markets in the Pharmaceutical Industry
  
• Personalized Medicine - What's Missing from the Dialogue
  
• Public-Private Partnerships in our New Global Healthcare Economy: A Call to Action for Industry, Government and Healthcare Leaders to Help Solve Global Health Problems and Pandemics
  
• Marketing Lower Cost, High-Quality Community Hospitals
  
• Personalized Medicine Begins Here
  
• The Challenges Securing Lifescience Financing in the "New Venture World"
  
• New Models for Consumer Engagement in Healthcare
  
• Intellectual Property's Role in Healthcare Reform
  
• Is it a French Paradox or an American Paradox?

David Green Elected President of HBS Healthcare Alumni

David Green, MBA '91 has been elected the next President of the HBS Health Industry Alumni Association.

David is currently President of Harvard Bioscience. He joined the Board of HBS Health Alumni as a director in 2006 and is now in his 2nd term. During this time David has been an active member serving as conference chairperson for three years in a row and alumni representative to the Studdent Healthcare Club.

David can be reached at dgreen@harvardbioscience.com.

Mara Aspinall selected for The PharmaVOICE 100 list : Commanders and Chiefs

Mara Aspinall, MBA '87, CEO of On-Q-ity has been named one of PharmaVOICE's top 100 leaders. In its July/August 2010 issue, the magazine identifies those C-suite leaders leaders who are forging new paths, anticipating trends, and initiating innovative strategies all while guiding their companies through a shifting marketplace. The entire list can be viewed at http://www.pharmavoice.com/pdfs/2010/pv-0710/PV0710_CommandersChiefs.pdf (access is only for a limited amount of time).

Ms. Aspinall started her diagnostics company On-Q-ity to advance the tools available to physicians and help them make the best decisions possible for individual cancer patients. Her leadership at Genzyme Pharamaceuticals and then Genzyme Genetics provided the foundation for the evolving personalized medicine field.

Mara most recently attended the HBS Healthcare Alumni Annual Biotech Council dinner in San Francisco in January. She can be reached at mara.aspinall@On-Q-ity.com.

Complete Genomics Files for IPO

Complete Genomics a Mountain View, Calif.-based human genome sequencing company, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol GNOM, with UBS Investment Bank and Jefferies & Co. serving as co-lead underwriters. The company has raised around $90 million in total VC funding since 2006, from Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management.

Complete Genomic's CEO Cliff Reid, MBA '83 was also named to the PharmaVOICE 100 list : Commanders and Chiefs. Dr. Reid's goal is to sequence 1 million genomes -- 1000 genomes in 1000 diseases that may lead to significant insights into human disease and result in earlier detection, more accurate diagnoses, and potentially more cures. The company expects to sequence 400 genomes per month by December 2010.

Cliff can be reached at creid@mba1983.hbs.edu.

Engage with HBS MBA Students Interested in Healthcare

Are you willing to share your healthcare industry expertise? Would you like to help a current HBS student?

The Healthcare Initiative at Harvard Business School is seeking alumni working in all sectors of the healthcare industry to mentor current MBA students. Last year the Healthcare Student-Alumni Mentor Program made over 100 matches between alumni working in healthcare and 1st and 2nd year HBS students.

Survey results indicate mentoring is an extremely rewarding experience for alumni and is highly valued by students. The mentor program requires a minimal time commitment on your part-email or phone conversations just a few times a year.

Please volunteer. To sign up to be a mentor, please complete this brief survey: http://poll.hbs.edu/poll/open/pollTakerOpen.jsp?poll=125974.

In addition, If you are willing to participate in networking events such as small dinners or coffee chats to meet with MBA students interested in healthcare or your company, please provide your contact information here: http://poll.hbs.edu/poll/open/pollTakerOpen.jsp?poll=128723.

For questions, please contact Erin Duffy, HBS Healthcare Initiative Coordinator (eduffy@hbs.edu).

New and Renewing HBS Health Members

HBS Health welcomes these new members and renewals from July 2010: